ABOUT THIS EVENT

Edgewise Therapeutics (Nasdaq: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders,

visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Kevin Koch, Ph.D., President and Chief Executive Officer, rings the Opening Bell.